PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS UNDERGOING ERCP ARE AT INCREASED RISK FOR PANCREATITIS: RECTAL INDOMETHACIN SIGNIFICANTLY REDUCES THE RISK

被引：0
|
作者：
Thiruvengadam, Nikhil
Forde, Kimberly A.
Chandrasekhara, Vinay
Kochman, Michael L.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30597-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
292
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [21] Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis
    Goldberg, David S.
    Camp, Amanda
    Martinez-Camacho, Alvaro
    Forman, Lisa
    Fortune, Brett
    Reddy, K. Rajender
    LIVER TRANSPLANTATION, 2013, 19 (03) : 250 - 258
  • [22] Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin
    Xiaoyu Kang
    Liyue Zheng
    Wei Zeng
    Shengye Yang
    Hao Sun
    Rongchun Zhang
    Xiangping Wang
    Biaoluo Wang
    Qin Tao
    Shaowei Yao
    Jie Chen
    Yanglin Pan
    Xuegang Guo
    Journal of Gastrointestinal Surgery, 2018, 22 : 1903 - 1910
  • [23] Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin
    Kang, Xiaoyu
    Zheng, Liyue
    Zeng, Wei
    Yang, Shengye
    Sun, Hao
    Zhang, Rongchun
    Wang, Xiangping
    Wang, Biaoluo
    Tao, Qin
    Yao, Shaowei
    Chen, Jie
    Pan, Yanglin
    Guo, Xuegang
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (11) : 1903 - 1910
  • [24] Complications of ERCP in patients with primary sclerosing cholangitis (PSC)
    Enns, R
    Eloubeidi, M
    Mergener, K
    Branch, MS
    Jowell, PS
    Baillie, J
    GASTROINTESTINAL ENDOSCOPY, 1998, 47 (04) : AB113 - AB113
  • [25] Complications after ERCP in patients with primary sclerosing cholangitis
    Etzel, Jason P.
    Eng, Sue C.
    Ko, Cynthia W.
    Lee, Scott D.
    Saunders, Michael D.
    Tung, Bruce Y.
    Kimmey, Michael B.
    Kowdley, Kris V.
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (04) : 643 - 648
  • [26] Use of thiopurines is not a risk factor for post-ERC pancreatitis in patients with primary sclerosing cholangitis
    Koskensalo, Vilja
    Aronen, Pasi
    Farkkila, Martti
    Kylanpaa, Leena
    Lindstrom, Outi
    Rainio, Mia
    Udd, Marianne
    Jokelainen, Kalle
    Tenca, Andrea
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (08) : 1020 - 1027
  • [27] Risk of Development of Cholangiocarcinoma in Patients With Atypical Cells on Brush Cytology During ERCP for Primary Sclerosing Cholangitis
    Hasan, Yazan
    Reddy, Aditi
    Murali, Arvind
    Silverman, William B.
    Johlin, Frederick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S40 - S40
  • [28] Risk factors for primary sclerosing cholangitis
    Boonstra, Kirsten
    de Vries, Elisabeth M. G.
    van Geloven, Nan
    van Erpecum, Karel J.
    Spanier, Marcel
    Poen, Alexander C.
    van Nieuwkerk, Carin M.
    Witteman, Ben J.
    Tuynman, Hans A.
    Naber, Anton H.
    Kingma, Paul J.
    Beuers, Ulrich
    Ponsioen, Cyriel Y.
    LIVER INTERNATIONAL, 2016, 36 (01) : 84 - 91
  • [29] Risk stratification in primary sclerosing cholangitis
    Mulinacci, Giacomo
    Cristoferi, Laura
    Palermo, Andrea
    Luca, Martina
    Gerussi, Alessio
    Invernizzi, Pietro
    Carbone, Marco
    MINERVA GASTROENTEROLOGY, 2023, 69 (01): : 84 - 94
  • [30] Prophylactic Rectal Indomethacin and Prophylactic Pancreatic Duct Stents (PPS) for Prevention of Post-ERCP Pancreatitis Are Underutilized in Average and High-Risk Patients Undergoing ERCP
    Issak, Abdulfatah
    Elangovan, Abbinaya
    Ferguson, Roy
    Waghray, Nisheet
    Sandhu, Dalbir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S39 - S39
12345